Skye Bioscience Statistics
Total Valuation
SKYE has a market cap or net worth of $12.48 billion. The enterprise value is $12.48 billion.
| Market Cap | 12.48B |
| Enterprise Value | 12.48B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SKYE has 971.55 million shares outstanding. The number of shares has increased by 215.43% in one year.
| Shares Outstanding | 971.55M |
| Shares Change (YoY) | +215.43% |
| Shares Change (QoQ) | -11.10% |
| Owned by Insiders (%) | 7.09% |
| Owned by Institutions (%) | 57.67% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84
| Current Ratio | 0.84 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -40.53 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -438.10% |
| Return on Capital (ROIC) | -1,398.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.42M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SKYE has paid $3,600 in taxes.
| Income Tax | 3,600 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +94,385.29% in the last 52 weeks. The beta is 1.71, so SKYE's price volatility has been higher than the market average.
| Beta (1Y) | 1.71 |
| 52-Week Price Change | +94,385.29% |
| 50-Day Moving Average | 12.45 |
| 200-Day Moving Average | 4.61 |
| Relative Strength Index (RSI) | 48.08 |
| Average Volume (30 Days) | 43,504 |
Short Selling Information
The latest short interest is 46,740, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 46,740 |
| Short Previous Month | n/a |
| Short % of Shares Out | 0.00% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -34.74M |
| Pretax Income | -37.64M |
| Net Income | -37.64M |
| EBITDA | -36.61M |
| EBIT | -36.73M |
| Earnings Per Share (EPS) | -$5.37 |
Balance Sheet
The company has $10.34 million in cash and $4.62 million in debt, giving a net cash position of $5.72 million or $0.01 per share.
| Cash & Cash Equivalents | 10.34M |
| Total Debt | 4.62M |
| Net Cash | 5.72M |
| Net Cash Per Share | $0.01 |
| Equity / Book Value | -2.13M |
| Book Value Per Share | -0.00 |
| Working Capital | -2.25M |
Cash Flow
In the last 12 months, operating cash flow was -$13.95 million and capital expenditures -$12,550, giving a free cash flow of -$13.96 million.
| Operating Cash Flow | -13.95M |
| Capital Expenditures | -12,550 |
| Free Cash Flow | -13.96M |
| FCF Per Share | -$1.99 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SKYE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -215.43% |
| Shareholder Yield | -215.43% |
| Earnings Yield | -0.30% |
| FCF Yield | -0.11% |
Analyst Forecast
The average price target for SKYE is $22.50, which is 75.10% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.50 |
| Price Target Difference | 75.10% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 8, 2023. It was a reverse split with a ratio of 1:250.
| Last Split Date | Sep 8, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:250 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |